To evaluate the efficacy of ceftaroline combined with specific carbapenems against ceftaroline-resistant MRSA strains.
Key Findings:
Ceftaroline combined with carbapenems restored activity against ceftaroline-resistant MRSA both in vitro and in vivo, highlighting a potential breakthrough in treatment options.
Synergistic effects were observed between ceftaroline and carbapenems, enhancing antimicrobial efficacy.
Combination therapy suppressed resistance and virulence gene expression.
Interpretation:
Combination therapy with ceftaroline and carbapenems presents a promising strategy to combat ceftaroline-resistant MRSA infections, potentially transforming clinical approaches to treatment and warranting further clinical investigation.
Limitations:
The study primarily focused on a single ceftaroline-resistant MRSA isolate.
Further clinical trials are needed to validate the findings in a broader context, including diverse MRSA strains.
Conclusion:
Ceftaroline and carbapenem combination therapy may provide an effective treatment option for difficult MRSA infections, particularly those resistant to ceftaroline, addressing a critical need in antibiotic resistance management.
by Joshua Olson, Valliammai Alaguvel, Gabriel Pérez-Parra, Allen Jankeel, Anuj K Khetarpal, Valeria Rodríguez-Guevara, Vanessa Vu, George Sakoulas, Erlinda R Ulloa
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
